Genetics of Cardiovascular and Neuromuscular Disease
Launched by UNIVERSITY OF CHICAGO · Aug 29, 2005
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding the genetics behind certain heart and muscle diseases, specifically cardiomyopathy (a heart condition), arrhythmias (irregular heartbeats), and muscular dystrophy (a group of diseases that weaken muscles). The researchers are looking for specific genes and mutations that may cause these conditions, as some genes can lead to both heart and muscle problems when they are changed in certain ways. By studying the DNA of patients, especially those from families where multiple members are affected, the goal is to better understand how these diseases develop.
Anyone of any age with a suspected inherited heart or muscle disorder may be eligible to participate, especially families with more than one person affected by these conditions. If someone does not have a suspected genetic condition related to the heart or muscles, they will not be included in the study. Participants can expect to provide samples for genetic testing, which could provide important insights into their health and potentially help researchers develop better treatments in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients of all ages will be considered for the study. In particular, families with more than one affected relative will be sought.
- Exclusion Criteria:
- • Subjects without a suspected inherited cardiovascular or neuromuscular disorder will be excluded from this study.
About University Of Chicago
The University of Chicago is a prestigious research institution renowned for its commitment to advancing medical science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, the University actively engages in cutting-edge research across various therapeutic areas. Its dedicated team of experienced investigators and state-of-the-art facilities enable the University of Chicago to conduct rigorous clinical studies aimed at improving patient outcomes and translating scientific discoveries into tangible healthcare solutions. The institution prioritizes ethical standards and patient safety, ensuring that all trials adhere to the highest regulatory guidelines and best practices in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
Elizabeth McNally, MD PhD
Principal Investigator
University of Chicago
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials